HighLife

Paris, France · Founded 2010 · Privately Held (backing)

Developer of a novel transcatheter replacement system designed to help in the treatment of mitral regurgitation. HighLife is based in Paris, France and was founded in 2010. It was valued at $534 million at its later-stage round in Sep 2026, the last priced event on record. It has raised $71 million across 1 recorded round; the latest was a $90 million later-stage round in Sep 2026.

PMV mark · valuation
$534.1M
Oct 2026
Priced at
its later-stage round
Sep 2026
Total raised
$71.0M
Last round
Later Stage VC
Sep 2026

Who backs HighLife?

14 investors · 1 led rounds
InvestorTypeRole
Supernova InvestVenture capitallead
Sofinnova PartnersVenture capital
BNP Paribas DéveloppementPE / buyout
European Investment BankOther
Andera PartnersPE / buyout
SPRIM Global InvestmentsOther
Vi PartnersVenture capital
Alter Domus Participations—
Jose Gordo—
LivaNova—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

HighLife investors

14 investors are on record for HighLife, including Supernova Invest, Sofinnova Partners, BNP Paribas Développement and European Investment Bank. By type, the record holds 3 venture capital firms and 3 private equity firms. 1 of them led a round. The later-stage round in Sep 2026 drew 13 investors.

Free account
More of HighLife with a free account
  • ·The post-money valuation on its round
  • ·The complete investor list: 14 names
  • ·Watch HighLife: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like HighLife. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View